Health

Restoring faith in governance and public action is itself a public good that would prepare us for a whole myriad of challenges on the horizon

As new coronavirus cases surge across India, calls are growing louder for wealthy countries to loosen intellectual property restrictions

School re-opening push based on outdated science is poorly timed in face of coronavirus resurgence

INET’s Commission on Global Economic Transformation - Interim Report on the Global Response to the Pandemic

“We’re building a data system, because you can’t really manage a city if you don’t know who’s there and what’s in it.”

“Equitable COVID19 vaccine distribution is a very important issue of global solidarity”

Capacity, Scale, and Control

Expert warns that it could be a race against the clock as the fast-spreading B117 variant picks up steam in the U.S.

Expert warns that without more robust abatement measures and testing, the virus could rage until mid-2022.

Warnings of “corruption and incompetence coming together,” as economists William Lazonick and Öner Tulum study the race to end the pandemic.

In this interview, Folashadé Soulé and Camilla Toulmin speak with Carl Manlan, the Chief Operating Officer of the Ecobank Foundation - responsible for Ecobank’s social impact engagement with the communities in which the bank operates in Africa – on the role of African philanthropy and corporate social responsibility in the response to COVID-19 on the continent.

Targeted Measures and Subsidies for Cost Effective COVID-19 Abatement

Dr. Ming Lin spoke out about Covid safety at his hospital and was fired. He’s fighting back against a system that put profits over human life.

Amid debates over costs—and profits—from a coronavirus vaccine, a new study shows that taxpayers have been footing the bill for every new drug approved between 2010 and 2019

Amid debates over costs—and profits—from a coronavirus vaccine, a new study shows that taxpayers have been footing the bill for every new drug approved between 2010 and 2019